Nobel laureate and GPCR pioneer Robert Lefkowitz and Septerna CEO Jeffrey Finer
Septerna files for Nasdaq listing as biotech IPOs come to life
Septerna is joining biotech’s IPO on-deck circle, preparing for a public offering with two other startups that have recently announced similar plans.
It announced its …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.